Novartis (NVS)
(Delayed Data from NYSE)
$100.21 USD
+0.61 (0.61%)
Updated May 9, 2024 04:00 PM ET
After-Market: $100.22 +0.01 (0.01%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth A Momentum B VGM
Brokerage Reports
Novartis AG [NVS]
Reports for Purchase
Showing records 461 - 475 ( 475 total )
Company: Novartis AG
Industry: Large Cap Pharmaceuticals
Company: Novartis AG
Industry: Large Cap Pharmaceuticals
Company: Novartis AG
Industry: Large Cap Pharmaceuticals
Company: Novartis AG
Industry: Large Cap Pharmaceuticals
Company: Novartis AG
Industry: Large Cap Pharmaceuticals
New and Recent Drug Launch Weekly Retail Sales Tracker
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Novartis AG
Industry: Large Cap Pharmaceuticals
New Drug Launch Weekly Retail Sales Tracker - Week Ended June 21
Provider: WEDBUSH SECURITIES INC.
Analyst: MARAI C
Company: Novartis AG
Industry: Large Cap Pharmaceuticals
Biotechnology/Biopharmaceuticals/BioDefense-New Drug Launch Weekly Retail Sales Tracker - Week Ending May 10
Provider: WEDBUSH SECURITIES INC.
Analyst: MARAI C
Company: Novartis AG
Industry: Large Cap Pharmaceuticals
Biotechnology/Biopharmaceuticals/BioDefense-New Drug Launch Weekly Retail Sales Tracker - Week ending February 22, 2013
Provider: WEDBUSH SECURITIES INC.
Analyst: MARAI C
Company: Novartis AG
Industry: Large Cap Pharmaceuticals
Griffin Securities Updates Coverage on Ligand Pharma. (LGND)
Provider: GRIFFIN SECURITIES, INC.
Analyst: MARKEY K
Company: Novartis AG
Industry: Large Cap Pharmaceuticals
Biotechnology / Biopharmaceuticals -Preview of Gout Abstracts at the Upcoming ACR
Provider: WEDBUSH SECURITIES INC.
Analyst: XU Y
Company: Novartis AG
Industry: Large Cap Pharmaceuticals
Calendar of Events
Provider: WALL STREET ACCESS CORP.
Company: Novartis AG
Industry: Large Cap Pharmaceuticals
RISK ARB TRADING UPDATE.
Provider: WALL STREET ACCESS CORP.
Company: Novartis AG
Industry: Large Cap Pharmaceuticals
MERGERS & ACQUISITIONS
Provider: WALL STREET ACCESS CORP.
Company: Novartis AG
Industry: Medical - Drugs
Company: Novartis AG
Industry: Medical - Drugs
Novartis agrees to exercise its call option to buy remainder of Alcon''s shares
Provider: IIR GROUP
Analyst: KHAN F